MLICM
QGENF

Metropolitan Life Insurance Company (MetLife)’s QIAGEN NV QGENF Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,535
Closed -$183K – 2602
2016
Q4 		$183K Sell
6,535
-150
-2% -$4.2K ﹤0.01% 2399
2016
Q3 		$183K Sell
6,685
-65
-1% -$1.78K ﹤0.01% 2392
2016
Q2 		$147K Buy
+6,750
New +$147K ﹤0.01% 2530
2014
Q3 		– Sell
-6,897
Closed -$169K – 2834
2014
Q2 		$169K Buy
6,897
+142
+2% +$3.48K ﹤0.01% 2610
2014
Q1 		$142K Hold
6,755
– – ﹤0.01% 2613
2013
Q4 		$161K Hold
6,755
– – ﹤0.01% 2606
2013
Q3 		$145K Buy
6,755
+237
+4% +$5.09K ﹤0.01% 2633
2013
Q2 		$130K Buy
+6,518
New +$130K ﹤0.01% 2623

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s QGENF Position: Q1 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 6,535 shares — an estimated $183K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in QGENF in Q2 2013 and held it in 8 quarters. The position peaked at $183K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,535 QIAGEN NV shares in Q1 2017, an estimated $183K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in QIAGEN NV in Q2 2013 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s QIAGEN NV position peaked at $183K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2017, filed 15 May 2017.